{"transactions":[{"id":1168179,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":52854,"kind":"person","name":"Moses Alan Charles","position":1,"cik":"0001819501","reported_name":"Moses Alan Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options - right to Buy","published_at":"2025-04-21T12:03:02.000Z","date":"2025-04-14","kind":"grant","planned":false,"acquired":true,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable over four years, with 25% of the shares of common stock subject to the option vesting on April 14, 2026, and the reminder vesting in 12 equal quarterly installments over three years."}],"balance_after":17600,"derivative":{"exercise_price":0.538,"expiration_date":"2035-04-14","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001213900-25-033478","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390025033478/ownership.xml","form_type":"4/A","original_submission_date":"2025-04-18"}},{"id":1168994,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":52854,"kind":"person","name":"Moses Alan Charles","position":1,"cik":"0001819501","reported_name":"Moses Alan Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options - right to Buy","published_at":"2025-04-18T20:01:06.000Z","date":"2025-04-14","kind":"grant","planned":false,"acquired":false,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable over four years, with 25% of the shares of common stock subject to the option vesting on April 14, 2026, and the reminder vesting in 12 equal quarterly installments over three years."}],"balance_after":17600,"derivative":{"exercise_price":0.538,"expiration_date":"2035-04-14","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001213900-25-033353","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390025033353/ownership.xml","form_type":"4"}},{"id":1454393,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":52854,"kind":"person","name":"Moses Alan Charles","position":1,"cik":"0001819501","reported_name":"Moses Alan Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options - Right to Buy","published_at":"2024-07-15T22:40:48.000Z","date":"2024-07-11","kind":"grant","planned":false,"acquired":true,"shares":176000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on July 11, 2025, and the remainder vesting in 12 equal quarterly installments over three years."}],"balance_after":176000,"derivative":{"exercise_price":0.363,"expiration_date":"2034-07-11","underlying":"Common Stock","underlying_shares":176000},"source":{"system":"sec-edgar","filing":"0001213900-24-061449","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390024061449/ownership.xml","form_type":"4"}},{"id":1939985,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":52854,"kind":"person","name":"Moses Alan Charles","position":1,"cik":"0001819501","reported_name":"Moses Alan Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2023-03-23T11:38:42.000Z","date":"2021-04-19","kind":"grant","planned":false,"acquired":true,"shares":11884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":11884,"derivative":{"exercise_price":27.26,"expiration_date":"2031-04-19","underlying":"American Depositary Shares","underlying_shares":11884},"source":{"system":"sec-edgar","filing":"0001178913-23-001115","document":"zk2329430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323001115/zk2329430.xml","form_type":"4"}},{"id":1939984,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":52854,"kind":"person","name":"Moses Alan Charles","position":1,"cik":"0001819501","reported_name":"Moses Alan Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2023-03-23T11:38:42.000Z","date":"2022-03-07","kind":"grant","planned":false,"acquired":true,"shares":6820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vested and became exercisable in their entirety on March 16, 2023. These options were granted as per the annual grant of options to directors."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":6820,"derivative":{"exercise_price":3.53,"expiration_date":"2032-03-07","underlying":"American Depositary Shares","underlying_shares":6820},"source":{"system":"sec-edgar","filing":"0001178913-23-001115","document":"zk2329430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323001115/zk2329430.xml","form_type":"4"}},{"id":1939983,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":52854,"kind":"person","name":"Moses Alan Charles","position":1,"cik":"0001819501","reported_name":"Moses Alan Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2023-03-23T11:38:42.000Z","date":"2023-03-16","kind":"grant","planned":false,"acquired":true,"shares":6857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest and become exercisable in their entirety on March 16, 2024, subject to the Reporting Person's continued service. These options were granted as per the annual grant of options to directors."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":6857,"derivative":{"exercise_price":1.62,"expiration_date":"2033-03-21","underlying":"American Depositary Shares","underlying_shares":6857},"source":{"system":"sec-edgar","filing":"0001178913-23-001115","document":"zk2329430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323001115/zk2329430.xml","form_type":"4"}},{"id":1971236,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":52854,"kind":"person","name":"Moses Alan Charles","position":1,"cik":"0001819501","reported_name":"Moses Alan Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options - Right to Buy","published_at":"2023-03-03T21:04:38.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 1, 2024, and the remainder vesting in 12 equal quarterly installments over three years."}],"balance_after":41000,"derivative":{"exercise_price":0.4,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":41000},"source":{"system":"sec-edgar","filing":"0001213900-23-017218","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390023017218/ownership.xml","form_type":"4"}},{"id":2312441,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":52854,"kind":"person","name":"Moses Alan Charles","position":1,"cik":"0001819501","reported_name":"Moses Alan Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options - Right to Buy","published_at":"2022-03-31T21:32:34.000Z","date":"2022-03-29","kind":"grant","acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 29, 2023, and the remainder vesting in 12 equal quarterly installments over three years."}],"balance_after":20500,"derivative":{"exercise_price":1.41,"expiration_date":"2032-03-29","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001213900-22-016991","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390022016991/ownership.xml","form_type":"4"}},{"id":2341226,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":52854,"kind":"person","name":"Moses Alan Charles","position":1,"cik":"0001819501","reported_name":"Moses Alan Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-03-09T21:04:03.000Z","date":"2021-04-19","kind":"grant","acquired":true,"shares":11884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":11884,"derivative":{"exercise_price":27.26,"expiration_date":"2031-04-19","underlying":"American Depositary Shares","underlying_shares":11884},"source":{"system":"sec-edgar","filing":"0001178913-22-001020","document":"zk2227454.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001020/zk2227454.xml","form_type":"4"}},{"id":2341225,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":52854,"kind":"person","name":"Moses Alan Charles","position":1,"cik":"0001819501","reported_name":"Moses Alan Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-03-09T21:04:03.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":6820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest and become exercisable in their entirety on March 16, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":6820,"derivative":{"exercise_price":3.53,"expiration_date":"2032-03-07","underlying":"American Depositary Shares","underlying_shares":6820},"source":{"system":"sec-edgar","filing":"0001178913-22-001020","document":"zk2227454.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001020/zk2227454.xml","form_type":"4"}},{"id":2620958,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":52854,"kind":"person","name":"Moses Alan Charles","position":1,"cik":"0001819501","reported_name":"Moses Alan Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant","published_at":"2021-07-30T13:48:03.000Z","date":"2021-07-28","kind":"purchase","acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock and common stock warrant were acquired in the issuer's registered direct offering of units, in which each unit consisted of one share of common stock and one common stock warrant to purchase 0.75 of a share of common stock, at a price of $4.00 per unit. The price paid per unit is reflected in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The common stock warrant will be exercisable six months after the date of issuance, at an exercise price of $5.00 per share and will expire five years from the date such warrant first becomes exercisable."}],"balance_after":3750,"derivative":{"exercise_price":5,"exercise_date":"2022-01-28","expiration_date":"2027-01-28","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001213900-21-039431","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390021039431/ownership.xml","form_type":"4"}},{"id":2620957,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":52854,"kind":"person","name":"Moses Alan Charles","position":1,"cik":"0001819501","reported_name":"Moses Alan Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-30T13:48:03.000Z","date":"2021-07-28","kind":"purchase","acquired":true,"shares":5000,"price":4,"value":20000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock and common stock warrant were acquired in the issuer's registered direct offering of units, in which each unit consisted of one share of common stock and one common stock warrant to purchase 0.75 of a share of common stock, at a price of $4.00 per unit. The price paid per unit is reflected in Table I."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001213900-21-039431","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390021039431/ownership.xml","form_type":"4"}},{"id":2742780,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":52854,"kind":"person","name":"Moses Alan Charles","position":1,"cik":"0001819501","reported_name":"Moses Alan Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase American Depositary Shares","published_at":"2021-04-21T21:15:06.000Z","date":"2021-04-19","kind":"grant","acquired":true,"shares":11884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":11884,"derivative":{"exercise_price":27.26,"expiration_date":"2031-04-19","underlying":"American Depositary Shares","underlying_shares":11884},"source":{"system":"sec-edgar","filing":"0001104659-21-053234","document":"tm2113689-4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000110465921053234/tm2113689-4_4.xml","form_type":"4"}},{"id":2763304,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":52854,"kind":"person","name":"Moses Alan Charles","position":1,"cik":"0001819501","reported_name":"Moses Alan Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options - Right to Buy","published_at":"2021-04-01T20:35:08.000Z","date":"2021-03-30","kind":"grant","acquired":true,"shares":15200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 30, 2022, and the remainder vesting in 12 equal quarterly installments over three years."}],"balance_after":15200,"derivative":{"exercise_price":7.02,"expiration_date":"2031-03-30","underlying":"Common Stock","underlying_shares":15200},"source":{"system":"sec-edgar","filing":"0001213900-21-019683","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390021019683/ownership.xml","form_type":"4"}},{"id":3012331,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":52854,"kind":"person","name":"Moses Alan Charles","position":1,"cik":"0001819501","reported_name":"Moses Alan Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options - Right to Buy","published_at":"2020-10-05T20:18:20.000Z","date":"2020-10-02","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on October 2, 2021, and the remainder vesting in 12 equal quarterly installments over three years."}],"balance_after":16000,"derivative":{"exercise_price":6.44,"expiration_date":"2030-10-02","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001213900-20-030124","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390020030124/ownership.xml","form_type":"4"}}]}